TheraVida Initiates Phase 2 Trial of THVD-201 for Overactive Bladder and Urinary Incontinence: selects Novotech
July 5, 2011 by Editor
Filed under Blog, Media Reports 2011
Multi-national Study to be Conducted by Novotech in Australia, New Zealand, and South Korea MOUNTAIN VIEW, California, and SYDNEY, Australia, May 16, 2011 /PRNewswire-iReach/ — TheraVida, Inc., a clinical stage biopharmaceutical company developing novel combination drug products, announced the start of a Phase 2 clinical trial of its lead product candidate THVD-201 for the treatment [...]
Novotech in new research collaboration: Biotechnology News
July 5, 2011 by Editor
Filed under Media Reports 2011
LEADING Australian contract clinical research company Novotech, Marine Biotechnology Australia and the University of Sydney are taking part in a new herpes research collaboration backed by the Academic Research Council (ARC). See full article
HERPES ZOSTER NOVEL TREATMENT HOPE FROM TASMANIAN ABALONE GETS $1.2 MILLION BOOST
June 15, 2011 by Editor
Filed under Company News 2010, Company News 2011
Sydney, Australia, 23 May 2011 – Leading Australian contract clinical research company Novotech, Marine Biotechnology Australia Pty Ltd [MBA] and the University of Sydney today announced a new Herpes research collaboration backed by the Academic Research Council [ARC]. The team aims to commercialize a novel treatment for Herpes simplex and Herpes zoster utilizing an extract [...]
